Literature DB >> 21431326

Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis.

Marit Dietel1, Norman Häfner, Lars Jansen, Matthias Dürst, Ingo B Runnebaum.   

Abstract

The coxsackie adenovirus receptor (CAR) is a component of the tight junction complex and involved in cell adhesion. Loss of CAR expression can affect cell adhesion which in the context of carcinogenesis may influence both invasion and metastatic spread. Functional inactivation of CAR may also result from the interaction with its soluble isoforms. To relate alterations of CAR expression to tumor progression, we aimed to establish a highly specific real-time PCR protocol for quantification of all splice variants. In the process of cloning, we identified a novel splice variant termed CAR4/6 that lacked exon 5 but retained exon 6 encoding the transmembrane domain. Localization of CAR4/6 in the cell membrane was confirmed by ectopic expression in HT1080 cells. Expression analyses using cDNA arrays revealed that most normal tissues, including those of the female genital tract, express full-length CAR (CAR6/7) but not CAR4/6. Differential expression of both CAR splice variants was validated in microdissected epithelia (n = 66) derived from normal cervical ectodermal tissue, high-grade cervical intraepithelial neoplasia (CIN2/3) and invasive squamous cervical carcinoma. CAR4/6 was not expressed in normal cervical tissue but in 42% of CIN2/3 and in most cervical carcinomas (p < 0.001). In contrast, CAR6/7 was detected in all of the microdissected samples. As for CAR4/6 expression levels of CAR6/7 were significantly lower in normal tissue as compared with CIN2/3 and cancer (p < 0.01). Ectopic expression of CAR4/6 in different cell lines enhanced the proliferative and invasive properties indicating a possible role in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431326     DOI: 10.1007/s00109-011-0742-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  38 in total

1.  Structure and chromosomal localization of the murine coxsackievirus and adenovirus receptor gene.

Authors:  Jin-Wen Chen; Ruma Ghosh; Robert W Finberg; Jeffrey M Bergelson
Journal:  DNA Cell Biol       Date:  2003-04       Impact factor: 3.311

2.  Solution structure of the coxsackievirus and adenovirus receptor domain 1.

Authors:  Shaokai Jiang; Amy Jacobs; Thomas M Laue; Michael Caffrey
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

3.  Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation.

Authors:  W M Korn; M Macal; C Christian; M D Lacher; A McMillan; K A Rauen; R S Warren; L Ferrell
Journal:  Cancer Gene Ther       Date:  2006-04-21       Impact factor: 5.987

4.  Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer.

Authors:  Kazumasa Matsumoto; Shahrokh F Shariat; Gustavo E Ayala; Katherine A Rauen; Seth P Lerner
Journal:  Urology       Date:  2005-08       Impact factor: 2.649

5.  The role of the extracellular domain in the biology of the coxsackievirus and adenovirus receptor.

Authors:  Katherine J D A Excoffon; Geri L Traver; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-18       Impact factor: 6.914

6.  Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3.

Authors:  Beibei Wang; Gang Chen; Fujun Li; Jianfeng Zhou; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

7.  The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure.

Authors:  T Okegawa; R C Pong; Y Li; J M Bergelson; A I Sagalowsky; J T Hsieh
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

8.  Expression of a human coxsackie/adenovirus receptor transgene permits adenovirus infection of primary lymphocytes.

Authors:  M R Schmidt; B Piekos; M S Cabatingan; R T Woodland
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

Review 9.  Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues.

Authors:  Yamato Kikkawa; Jeffrey H Miner
Journal:  Connect Tissue Res       Date:  2005       Impact factor: 3.417

10.  The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis.

Authors:  Elisabeth Raschperger; Johan Thyberg; Sven Pettersson; Lennart Philipson; Jonas Fuxe; Ralf F Pettersson
Journal:  Exp Cell Res       Date:  2006-03-15       Impact factor: 3.905

View more
  7 in total

Review 1.  Potential molecular targeting of splice variants for cancer treatment.

Authors:  Christopher A Blair; Xiaolin Zi
Journal:  Indian J Exp Biol       Date:  2011-11       Impact factor: 0.818

2.  Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients.

Authors:  Xue Yang; Shuangshuang Li; Huiju Wang; Wanyuan Chen; Xiaozhou Mou; Shibing Wang
Journal:  Oncol Lett       Date:  2018-12-24       Impact factor: 2.967

3.  IL-7 splicing variant IL-7δ5 induces EMT and metastasis of human breast cancer cell lines MCF-7 and BT-20 through activation of PI3K/Akt pathway.

Authors:  Jie Yang; Zhi Zeng; Yuyu Peng; Jianhua Chen; Ling Pan; Deshun Pan
Journal:  Histochem Cell Biol       Date:  2014-04-26       Impact factor: 4.304

4.  Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis.

Authors:  M Reeh; M Bockhorn; D Görgens; M Vieth; T Hoffmann; R Simon; J R Izbicki; G Sauter; U Schumacher; M Anders
Journal:  Br J Cancer       Date:  2013-09-10       Impact factor: 7.640

5.  Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population.

Authors:  Ying-Yu Ma; Xiao-Jun Wang; Yong Han; Gang Li; Hui-Ju Wang; Shi-Bing Wang; Xiao-Yi Chen; Fan-Long Liu; Xiang-Lei He; Xiang-Min Tong; Xiao-Zhou Mou
Journal:  Mol Med Rep       Date:  2016-07-21       Impact factor: 2.952

6.  Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses.

Authors:  Joseph Hoare; Nicola Campbell; Elisabete Carapuça
Journal:  Porto Biomed J       Date:  2018-06-29

7.  The Coxsackievirus and Adenovirus Receptor Has a Short Half-Life in Epithelial Cells.

Authors:  Poornima Kotha Lakshmi Narayan; James M Readler; Mahmoud S Alghamri; Trisha L Brockman; Ran Yan; Priyanka Sharma; Vladislav Snitsarev; Katherine J D A Excoffon; Abimbola O Kolawole
Journal:  Pathogens       Date:  2022-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.